Eric is Senior Director of Neuroscience Innovation at the Johnson & Johnson Innovation Center, Boston. Eric has more than 23 years of drug discovery and development experience with an extensive background in the biology and pharmacology of CNS disorders.
Previously Eric was Director of Neuroscience Clinical Biomarkers at Bristol-Myers Squibb where he was responsible for developing the translational strategies for early clinical programs in the areas of schizophrenia, depression and neuromuscular diseases. Other previous roles held by Eric include Senior Director of Neuroscience Discovery at Pfizer where he was responsible for leading preclinical pharmacology teams and Director of Neuropharmacology at CHDI where he was responsible for initiating and managing biotech and academic partnerships focused on Huntington’s disease.
Eric received a BA in Biology from Colgate University and a PhD in Molecular Biology from the Albert Einstein College of Medicine. He went on to do postdoctoral fellowships at the Massachusetts Institute of Technology and Rockefeller University prior to initiating a career in the pharmaceutical industry.